Article Versions Notes

Kampan NC, Kartikasari AER, Deceneux C, Madondo MT, McNally OM, Flanagan KL, Aziz NA, Stephens AN, Reynolds J, Quinn MA, et al. Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses. Cancers. 2023; 15(3):667. https://doi.org/10.3390/cancers15030667

Kampan, Nirmala Chandralega, Apriliana Ellya Ratna Kartikasari, Cyril Deceneux, Mutsa Tatenda Madondo, Orla M. McNally, Katie Louise Flanagan, Norhaslinda A. Aziz, Andrew N. Stephens, John Reynolds, Michael A. Quinn, and et al. 2023. "Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses" Cancers 15, no. 3: 667. https://doi.org/10.3390/cancers15030667

Kampan, N. C., Kartikasari, A. E. R., Deceneux, C., Madondo, M. T., McNally, O. M., Flanagan, K. L., Aziz, N. A., Stephens, A. N., Reynolds, J., Quinn, M. A., & Plebanski, M. (2023). Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses. Cancers, 15(3), 667. https://doi.org/10.3390/cancers15030667